Pharmaceuticals Manufacturing Company
With Latest Technology
Recognized as one of the most fastest growing pharmaceutical manufacturing companies of complex molecules using the latest technologies. Our commitment to uncompromising quality is reflected in a wide range of prestigious international certifications, including EU-GMP, PIC/S (ANDA), INVIMA, COFEPRIS, DIGEMID, and many others. These accreditations affirm our consistent adherence to global standards in pharmaceutical excellence.
Milestones
• First Manufacturing Setup at Amritsar
with
Generic Liquid Orals & Injectables Facility (1983)
• Target Markets of Africa & ASEAN Countries (2000)
• New manufacturing with OSD and Injectable capabilities for general
therapiesand beta-lactam added (2007)
• Started Marketing Office in Africa • Setup of new manufacturing in HP (2010)
• WHO approval for Amritsar facility
• New facility setup for Oncology products
• Started Exporting to Gulf Countries (2012)
• Libya, Ivory Coast, Nigeria approval for
Amritsar facility (2015)
• Listed on BSE SME Exchange (2016)
• Upgraded Generics Block (2017)
• PICs/GMP from Iran, Iraq & Tanzania
• Upgraded Oncology facility Unit 3 in HP (2018)
• New Cephalosporin facility in HP (2019)
• 11 molecules registered in EMs
• WHO approval for Cephalosporin Unit
• Enhanced injectables capabilities at Amritsar (2021)
• Established Beta-lactam Unit
• Developed 10+ complex products including
microspheres, Liposomes, Ophthalmic susp.
• PIC/s GMP from Brazil for 3 Units
• Migrated to Main Board of BSE Ltd (2022)
• EU-GMP for Cephalosporin & Oncology Unit
• Established Biologics Unit (2023)
• PIC/s approval for Beta Lactam Unit
• Comercialized product in EU
• SFDA (PICs) approval for General Injectable Unit
• Promising results for KPL First Biologics
KWAI POIETIN
• DSIR approval for KPL "Innovation Center" (R&D)
Milestones
Got registered with
the Bombay Stock Exchange in 2016
Continuous upgradation of our state of the art manufacturing units by installing the latest equipment for the production of best quality products.
Started production of Cytotoxic drugs, following EU standards at our new unit at Jassur, Himachal Pradesh.
Attained PIC/S GMP accreditation for FDA, Iran
Developed our own integrated software – “Friends” – for prompt updates for customer service and information
World-class QA, QC, Micro Lab, R&D to ensure best in class quality
11 Molecules registered in emerging markets
WHO approved for cephalosporin unit
Enhanced injectables capabilities at Amritsar facility
Developed over 10 comples products including microspheres, Liposomes, Ophthalmic susp, etc
Our Vision
Developing Niche Injectables at Affordable Prices. We want to be a leading pharmaceutical company in India and to become a significant global player by providing high quality, affordable and innovative solutions in medicine and treatment.
Our Commitment
Develop & Manufacture Niche products that address real health problems.
1. We are committed to manufacture innovative and quality products that are economically viable for our customers.
2. Providing value to our investors, all within a supportive environment.
3. Rewarding the work environment for our employees.
4. We are responsible to society. We shall be good corporate citizens and will be driven by high ethical standards in our practices.
Knowledge
The main expertise of our knowledge is used in Reverse engineering of immediate off-patent drugs. We are experts in developing testing and manufacturing procedures. The whole process is to achieve safety, efficacy, and quality of the formulation. It is the knowledge which helps in giving customer satisfaction.
Trust
Our Trust is about acting with integrity on the high-value business relationship and its needs to secure the future for both supplier and buyer.
